We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Kit Purifies RNA from Very Small Samples

By LabMedica International staff writers
Posted on 29 Apr 2015
A new kit for RNA purification prior to microarray analysis was designed specifically for small samples and for particularly difficult to isolate targets such as subpopulations of cells within larger samples like those found in heterogeneous solid tumors or hematologic malignancies.

Traditional whole-transcriptome expression analysis depends on samples derived from a relatively large number of cells. More...
However, the gene expression measurements from these large cell populations represent an average that can often mask key differences between subpopulations. To better understand the biological significance of these differences in gene expression, researchers are increasingly focusing on smaller, characterized subsets of cells.

To accommodate these researchers Affymetrix (Santa Clara, CA, USA) developed the GeneChip WT Pico Kit for gene expression array target preparation, which can be used with as little as 100 picograms of total RNA, the amount that can be obtained from about 10 cells.

The new WT Pico Kit is compatible with small sample isolation techniques, including flow cytometry, laser capture microdissection, and fine needle aspiration. The kit prepares targets from multiple sample types, including fresh and fresh frozen tissues, cultured cells, FFPE specimens, and whole blood samples without a globin mRNA reduction step.

“In addition to conserving samples and enabling analysis of samples that may only contain small amounts of RNA, the ability to zero in on smaller sets of cells can reveal information that is hidden in larger cell populations,” said Christian Reece, product manager at Affymetrix. “Cancer researchers working with solid tumors and hematologic malignancies are particularly interested at looking at smaller and smaller groups of cells.”

Related Links:

Affymetrix



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.